- Home
- ICCM vs NDRA Comparison
ICCM vs NDRA Comparison
Compare ICCM & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICCM | NDRA |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 8.1M |
| IPO Year | 2013 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ICCM | NDRA |
|---|---|---|
| Price | $1.63 | $5.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $2.50 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 86.1K | 64.0K |
| Earning Date | 05-27-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $139.51 | N/A |
| Revenue Next Year | $75.66 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $2.96 |
| 52 Week High | $9.54 | $9.83 |
Technical Indicators
Market Signals| Indicator | ICCM | NDRA |
|---|---|---|
| Relative Strength Index (RSI) | 22.40 | 51.86 |
| Support Level | $0.22 | $4.48 |
| Resistance Level | $2.50 | $6.35 |
| Average True Range (ATR) | 0.16 | 0.60 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 4.71 | 47.46 |
Price Performance
Historical ComparisonAbout ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.